BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31138526)

  • 1. Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues
    Xue Y; Barker N; Hoon S; He P; Thakur T; Abdeen SR; Maruthappan P; Ghadessy FJ; Lane DP
    Cancer Res; 2019 Jul; 79(14):3595-3607. PubMed ID: 31138526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
    Wu T; Chen W; Zhong Y; Hou X; Fang S; Liu CY; Wang G; Yu T; Huang YY; Ouyang X; Li HQ; Cui L; Yang Y
    Mol Cancer Ther; 2017 Apr; 16(4):717-728. PubMed ID: 27903750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
    Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
    Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
    He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
    Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
    Dabiri Y; Kalman S; Gürth CM; Kim JY; Mayer V; Cheng X
    Sci Rep; 2017 Jul; 7(1):5423. PubMed ID: 28710427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53.
    Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J
    Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
    Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
    Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitor bortezomib stabilizes and activates p53 in hematopoietic stem/progenitors and double-negative T cells in vivo.
    Xue Y; San Luis B; Dress RJ; Murad KBA; Ginhoux F; Barker N; Lane D
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2219978120. PubMed ID: 36940336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.
    Song X; Dilly AK; Choudry HA; Bartlett DL; Kwon YT; Lee YJ
    Mol Cancer Res; 2015 Dec; 13(12):1533-43. PubMed ID: 26354682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.
    Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J
    Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
    Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
    Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut.
    Bach SP; Williamson SE; O'Dwyer ST; Potten CS; Watson AJ
    Br J Cancer; 2006 Jul; 95(1):35-41. PubMed ID: 16804527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) promote cell proliferation in colorectal cancer by affecting P53.
    Zhao Y; Qin ZS; Feng Y; Tang XJ; Zhang T; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):976-984. PubMed ID: 29509245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Colon Cancer Effects of 6-Shogaol Through G2/M Cell Cycle Arrest by p53/p21-cdc2/cdc25A Crosstalk.
    Qi LW; Zhang Z; Zhang CF; Anderson S; Liu Q; Yuan CS; Wang CZ
    Am J Chin Med; 2015; 43(4):743-56. PubMed ID: 26119958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
    Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
    Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.